Riskpilot← Back to searchSign inGet full accessProzymex 2017 ApS
APSActiveCVR 40010114Agern Alle 3Manufacture of other organic basic chemicals · NACE 2014Est. 2018— employees
Revenue 2025
DKK -25K
-28% vs 2024
EBITDA margin
100.0%
+28% vs 2024
Equity ratio
96.3%
Financial strength
Net profit 2025
DKK -23K
+70% vs 2024
| Revenue | DKK -25K | -28% |
| EBITDA | DKK -25K | +28% |
| Net profit | DKK -23K | +70% |
| Total assets | DKK 2,8M | -1% |
| Equity | DKK 2,7M | -1% |
| Employees | — | — |
Legal name
Prozymex 2017 ApS
CVR number
40010114
Legal form
Anpartsselskab
NACE code
2014 · Manufacture of other organic basic chemicals
Founded
19. september 2018
Share capital
DKK 500.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af et bestyrelsesmedlem i forening med en direktør.
Company purpose
Selskabets formål er at udvikle og sælge farmaceutiske produkter.
Address
Agern Alle 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -157 | -66 | 14.639 | -34 | -25 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -157 | -66 | 14.639 | -34 | -25 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -157 | -66 | 14.639 | -34 | -25 |
| Net financials | 206 | 232 | 272 | -47 | 1 |
| Profit before tax | 50 | 166 | 14.911 | -81 | -23 |
| Tax | -36 | -13 | 3.256 | -4 | -1 |
| Net profit | 86 | 179 | 11.655 | -77 | -23 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6.715 | 6.884 | 9.260 | 2.858 | 2.841 |
| Equity | 6.662 | 6.841 | 6.997 | 2.760 | 2.737 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 53 | 43 | 2.263 | 99 | 104 |
| Total debt | 53 | 43 | 2.263 | 99 | 104 |
EBITDA margin
-2464300.0%
This company
15.8%
Market median
-15596935% vs market
20212025
Equity ratio
96.3%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
-0.8%
This company
18.4%
Market median
-104% vs market
20212025
Net profit margin
-2283000.0%
This company
8.1%
Market median
-28185285% vs market
20212025
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Management | Management | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LJP HOLDING ApS
Prozymex 2017 ApS Board members of Prozymex 2017 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Pedersen | Management | 0 companies |
| Lone Ballegaard Pedersen | Board of Directors | 0 companies |